Tomas J. Philipson - 26 Jun 2026 Form 4 Insider Report for JUPITER NEUROSCIENCES, INC. (JUNS)

Reporting relationship: Director
Issuer ticker: JUNS
Reported as of: 26 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 01 Jul 2026, 16:02:03 UTC
Source filing: View source filing
Reporting owner signature: /s/ Tomas J. Philipson

Key filing fact

Tomas J. Philipson filed Form 4 for JUPITER NEUROSCIENCES, INC. (JUNS) on 01 Jul 2026.

Key facts

This page summarizes Tomas J. Philipson's Form 4 filing for JUPITER NEUROSCIENCES, INC. (JUNS).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 01 Jul 2026, 16:02.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002142237 Primary reporting owner

Philipson Tomas Jan

Relationship: Director
Address: C/O JUPITER NEUROSCIENCES, INC., 1001 NORTH US HYWAY 1, SUITE 504, JUPITER
Signature: /s/ Tomas J. Philipson
Signature date: 01 Jul 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

JUNS transaction Derivative

Stock Option (right to buy)

Award

Transaction value
Shares: +536,428
Change %
Price: $0.000000^*
Shares after: 536,428
Date: 29 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 536,428
Exercise price: $0.2100
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents a grant of 536,428 stock options (each representing the right to purchase one share of Common Stock) under the Issuer's 2025 Equity Incentive Plan. Of this amount, 90,000 options were granted in connection with the Reporting Person's appointment to the Board of Directors and 446,428 options were granted in lieu of cash compensation otherwise payable as an annual board retainer and committee fees. The options vest in 12 equal quarterly installments beginning September 2, 2026, subject to the Reporting Person's continued service as a director through each vesting date.